chr2-46994386-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_020458.4(TTC7A):āc.873G>Cā(p.Leu291=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00977 in 1,613,746 control chromosomes in the GnomAD database, including 95 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0069 ( 5 hom., cov: 32)
Exomes š: 0.010 ( 90 hom. )
Consequence
TTC7A
NM_020458.4 synonymous
NM_020458.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.796
Genes affected
TTC7A (HGNC:19750): (tetratricopeptide repeat domain 7A) This gene encodes a protein containing tetratricopeptide repeats. Mutations in this gene disrupt intestinal development and can cause early onset inflammatory bowel disease and intestinal atresia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 2-46994386-G-C is Benign according to our data. Variant chr2-46994386-G-C is described in ClinVar as [Benign]. Clinvar id is 458804.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.796 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00693 (1056/152280) while in subpopulation NFE AF= 0.0124 (845/68012). AF 95% confidence interval is 0.0117. There are 5 homozygotes in gnomad4. There are 457 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTC7A | NM_020458.4 | c.873G>C | p.Leu291= | synonymous_variant | 7/20 | ENST00000319190.11 | NP_065191.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTC7A | ENST00000319190.11 | c.873G>C | p.Leu291= | synonymous_variant | 7/20 | 2 | NM_020458.4 | ENSP00000316699 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00694 AC: 1056AN: 152162Hom.: 5 Cov.: 32
GnomAD3 genomes
AF:
AC:
1056
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00653 AC: 1635AN: 250204Hom.: 4 AF XY: 0.00670 AC XY: 907AN XY: 135336
GnomAD3 exomes
AF:
AC:
1635
AN:
250204
Hom.:
AF XY:
AC XY:
907
AN XY:
135336
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0101 AC: 14717AN: 1461466Hom.: 90 Cov.: 31 AF XY: 0.00980 AC XY: 7123AN XY: 727012
GnomAD4 exome
AF:
AC:
14717
AN:
1461466
Hom.:
Cov.:
31
AF XY:
AC XY:
7123
AN XY:
727012
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00693 AC: 1056AN: 152280Hom.: 5 Cov.: 32 AF XY: 0.00614 AC XY: 457AN XY: 74454
GnomAD4 genome
AF:
AC:
1056
AN:
152280
Hom.:
Cov.:
32
AF XY:
AC XY:
457
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2024 | TTC7A: BP4, BP7, BS1, BS2 - |
Multiple gastrointestinal atresias Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at